Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications

The summary for the Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD) invite the small business community to apply cutting edge technology to research to develop new approaches to prevent, treat, and cure type 1 diabetes and its complications. This RFA will utilize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) mechanisms, but will be run in parallel with other requests for applications (RFAs) of similar scientific scope (DK- 03-015 for Innovative Partners and DK-03-001 for Bench to Bedside) that will utilize the traditional research project grant (R01), the exploratory/developmental grant (R21) or the exploratory/developmental grant phase II (R33) grant mechanisms.
Federal Grant Title: Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications
Federal Agency Name: National Institutes of Health
Grant Categories: Income Security and Social Services Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-03-020
Type of Funding: Grant
CFDA Numbers: 93.36193.837
CFDA Descriptions: Nursing Research 93.837 Heart and Vascular Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Feb 19, 2004
Posted Date: Aug 29, 2003
Creation Date: Mar 20, 2004
Archive Date: Mar 20, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.847 -- Diabetes, Endocrinology and Metabolism Research
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster